Company page

Invex Therapeutics Ltd.

Invex Therapeutics Ltd. is a public company listed on the Australian market under the ticker IXC, with a market capitalization of approximately AUD 5.92 million. The company focuses on developing innovative therapies for neurological conditions. Its commitment to advancing medical science positions it as a notable player in the healthcare sector.